Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy
about
Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failureTargeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathyActivating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidismModulation of cardiocyte functional activity by antibodies against trypanosoma cruzi ribosomal P2 protein C terminus.HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathyRole of autoimmunity in dilated cardiomyopathyAbsence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.Predicting adverse side effects of drugsImpact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.Unresolved issues in theories of autoimmune disease using myocarditis as a frameworkAutoantibodies and cardiovascular dysfunction: cause or consequence?β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.Receptor-activating autoantibodies and disease: preeclampsia and beyond.Cardiomyopathies.Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression.Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.Antibodies against G-protein coupled receptors: novel uses in screening and drug development.Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.Circulating miR-185 might be a novel biomarker for clinical outcome in patients with dilated cardiomyopathyRole of autoantibodies in the physiopathology of Chagas' disease.Effects of muscarinic acetylcholine 3 receptor(208-227) peptide immunization on autoimmune response in nonobese diabetic mice.The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors.Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.The auto-antigen repertoire in myasthenia gravis.The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionActivating autoantibodies and cardiovascular disease.The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptors.Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy.β1 -adrenergic receptor autoantibodies from heart failure patients enhanced TNF-α secretion in RAW264.7 macrophages in a largely PKA-dependent fashion.Abnormal immune system and hypertension: where are we?High level functional expression of human beta 1-adrenergic receptor in baculovirus-infected cells screened by a rapid in situ procedure.
P2860
Q24652847-B9E3FD91-5588-4E21-A185-2D732AE40B56Q27000434-0D2DA05F-6208-4E60-AEB7-23DADBA78E98Q33570881-02DCC553-BF4D-4695-BCC7-EA3390DCEEE5Q33598996-72E801EB-A943-43E2-9531-49647D052D4EQ33611977-59C9D817-6B2B-4BFF-84C0-9AD12C2596D4Q33614482-98C828F9-28F0-4388-A37F-FD2DEB0D5395Q33675266-5356592E-6C94-4040-8FE6-806E4E775C95Q33898493-C978952A-AC22-4FAE-BA44-24AB9AD2318AQ33898777-378F112D-CF1F-4BBC-A8F8-690CE4B97861Q34173771-35BDE7D0-AF9E-4993-9F31-C245D8320430Q34315311-798B857B-2BF5-45FB-97FE-6CAAE4CA452BQ34452486-DFB83FA1-826C-4717-92BA-D065CF8564E0Q34473885-7E66E41C-509B-4B4B-87A0-6050B8196716Q34541400-018F790E-9166-4E54-BCCB-ED67BF50AB0EQ34572245-944CE888-9E18-4627-9CA0-4A0D9BDB3346Q34574067-7B8FB2BA-3F57-4FBB-90F7-340B1436EE76Q35023544-A97A39FC-2E41-4219-B6A2-1A4CAE8D87B3Q35026111-5827F246-388C-4F27-99E2-14E2AF1229F6Q35707881-31E4CB7E-816F-4656-950F-DD4C5CC49026Q35934767-058A0F3A-3561-4C8A-B5A0-65037D8FDAD3Q36365071-3ED5D5CC-ABB4-4262-875D-EBB69FC9E741Q36839586-5AA418D1-8B69-47EB-9357-9B430DEF9660Q36971570-DA93CCC4-F5A1-4F90-91EE-F45852A7EF18Q37051232-A1C040CD-39B3-4441-89B6-4FF5BB3AF152Q37233054-BA5F3CEB-92CB-456B-81D2-832DAEDB9CF7Q37264363-90199562-31A2-4A13-A0F8-6A730D087045Q37267209-BE424BD9-8F7C-442F-A340-E4C9C3007763Q37325527-499B9BB7-BAFD-41D9-8D42-9AFE4601581AQ37412285-EFC01EBC-5016-4F7D-9C0C-20ACAC4E5F44Q37510542-19927A72-51B8-4F3C-87F4-2D2DA8BF888FQ37593696-C98FC8AC-CFB7-423B-A7A7-A961B3C2E047Q37727984-955B119D-CF0F-4F1B-ADF2-A3F9D09EC81DQ37824303-B8859FBF-114B-43C2-9E3C-A38B2EB3EC84Q37973384-671DC505-177D-4ED3-979E-42C16D09B01FQ38118625-389163FC-7FC8-4F45-ABC3-C8952B4F4813Q38162971-F10816EA-9C75-4681-818F-9389D280CFBAQ39334546-6EEAEF9D-6D8F-4999-B463-30E7E0FEAE9DQ39342487-8508B6DC-6A3C-4907-82FD-B3990F7A7B36Q40999881-FED37A39-A53D-44B1-B3A5-938E101C818EQ42070602-42A4712F-2B53-49B8-A548-85C10D2A487C
P2860
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@ast
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@en
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@nl
type
label
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@ast
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@en
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@nl
prefLabel
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@ast
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@en
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@nl
P2093
P2860
P356
P1476
Mapping of a functional autoim ...... opathic dilated cardiomyopathy
@en
P2093
Andersson B
Guillet JG
Hjalmarson A
Magnusson Y
Strosberg AD
Waagstein F
P2860
P304
P356
10.1172/JCI114888
P407
P577
1990-11-01T00:00:00Z